UY30082A1 - Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos - Google Patents
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentosInfo
- Publication number
- UY30082A1 UY30082A1 UY30082A UY30082A UY30082A1 UY 30082 A1 UY30082 A1 UY 30082A1 UY 30082 A UY30082 A UY 30082A UY 30082 A UY30082 A UY 30082A UY 30082 A1 UY30082 A1 UY 30082A1
- Authority
- UY
- Uruguay
- Prior art keywords
- methyl
- glucopyranoside
- fluoro
- preparation
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
La invencinn se refiere a una forma cristalina de 1`-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil-5`-meton-1H-pirazol-3N-B-D-glucopirannsido, a un mctodo para la preparacinn de la misma, ase como al uso de la misma para preparar medicamentos
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06000483 | 2006-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30082A1 true UY30082A1 (es) | 2007-08-31 |
Family
ID=35953998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30082A UY30082A1 (es) | 2006-01-11 | 2007-01-05 | Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos |
Country Status (19)
Country | Link |
---|---|
US (2) | US7524822B2 (es) |
EP (1) | EP1976859A1 (es) |
JP (1) | JP4936234B2 (es) |
KR (1) | KR20090012205A (es) |
CN (1) | CN101370816A (es) |
AR (1) | AR058962A1 (es) |
AU (1) | AU2007204368A1 (es) |
BR (1) | BRPI0706375A2 (es) |
CA (1) | CA2635203A1 (es) |
EA (1) | EA200801663A1 (es) |
EC (1) | ECSP088501A (es) |
IL (1) | IL192655A0 (es) |
NO (1) | NO20082395L (es) |
NZ (1) | NZ570311A (es) |
PE (1) | PE20071237A1 (es) |
TW (1) | TW200745149A (es) |
UY (1) | UY30082A1 (es) |
WO (1) | WO2007080170A1 (es) |
ZA (1) | ZA200804151B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031203A1 (ja) * | 2002-10-04 | 2004-04-15 | Kissei Pharmaceutical Co., Ltd. | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ES2548578T3 (es) * | 2007-12-27 | 2015-10-19 | Kissei Pharmaceutical Co., Ltd. | Monosebacato de un derivado de pirazol |
CN102007138B (zh) * | 2008-04-16 | 2014-05-21 | 橘生药品工业株式会社 | 吡唑衍生物的半富马酸盐 |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
KR101019079B1 (ko) * | 2010-12-28 | 2011-03-07 | 최점미 | 돌침대용 온열 제어장치 |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014161836A1 (en) | 2013-04-04 | 2014-10-09 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
AU2014364999B2 (en) | 2013-12-17 | 2019-12-12 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in feline animals |
EP3096765B1 (en) * | 2014-01-23 | 2018-12-05 | Boehringer Ingelheim Vetmedica GmbH | Treatment of metabolic disorders in canine animals |
CN106061950B (zh) * | 2014-02-28 | 2019-05-03 | 住友化学株式会社 | 吡唑化合物的制造方法 |
AU2015239655B2 (en) | 2014-04-01 | 2019-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
AU2015320975B2 (en) | 2014-09-25 | 2020-10-08 | Boehringer Ingelheim Vetmedica Gmbh | Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals |
CN105061322B (zh) * | 2015-07-27 | 2018-07-24 | 北京颖泰嘉和生物科技股份有限公司 | N-取代的3-羟基吡唑化合物的制备方法 |
US10220017B2 (en) | 2015-08-27 | 2019-03-05 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising SGLT-2 inhibitors |
US20230381101A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA71994C2 (en) | 1999-08-31 | 2005-01-17 | Kissei Pharmaceutical | Glucopyranosyloxypyrazole derivatives, a pharmaceutical composition containing these derivatives and intermediate compounds for the preparation thereof |
WO2002036602A1 (fr) * | 2000-11-02 | 2002-05-10 | Ajinomoto Co., Inc. | Nouveaux derives du pyrazole et remedes au diabete contenant ces derniers |
RU2317302C2 (ru) | 2000-12-28 | 2008-02-20 | Киссеи Фармасьютикал Ко., Лтд. | Производные глюкопиранозилоксипиразола и их применение в лекарственных средствах |
TW593329B (en) | 2001-02-26 | 2004-06-21 | Kissei Pharmaceutical | Glucopyranosyloxypyrazole derivatives and pharmaceutical uses thereof |
WO2002083857A2 (en) | 2001-04-10 | 2002-10-24 | Millennium Pharmaceuticals, Inc. | 68723, sodium/glucose cotransporter family members and uses therefor |
JP4292570B2 (ja) | 2001-04-27 | 2009-07-08 | 味の素株式会社 | N−置換ピラゾール−o−グリコシド誘導体及びそれらを含有する糖尿病治療薬 |
US7217697B2 (en) | 2001-05-30 | 2007-05-15 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor |
JP4115105B2 (ja) | 2001-07-02 | 2008-07-09 | 協和醗酵工業株式会社 | ピラゾール誘導体 |
US20030087843A1 (en) | 2001-09-05 | 2003-05-08 | Washburn William N. | O-pyrazole glucoside SGLT2 inhibitors and method of use |
EP1500403A4 (en) | 2002-04-26 | 2008-09-17 | Ajinomoto Kk | MEANS FOR THE PREVENTION / TREATMENT OF DIABETES |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
ITBO20020050U1 (it) | 2002-05-13 | 2003-11-13 | Netpack S R L | Contenitore per prodotti ortofrutticoli |
JP4540475B2 (ja) | 2002-08-08 | 2010-09-08 | キッセイ薬品工業株式会社 | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
WO2004019958A1 (ja) | 2002-08-27 | 2004-03-11 | Kissei Pharmaceutical Co., Ltd. | ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途 |
WO2004031203A1 (ja) | 2002-10-04 | 2004-04-15 | Kissei Pharmaceutical Co., Ltd. | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
WO2004050122A1 (ja) | 2002-12-04 | 2004-06-17 | Kissei Pharmaceutical Co., Ltd. | 高血糖症に起因する疾患の予防又は治療剤 |
US7439232B2 (en) * | 2003-04-01 | 2008-10-21 | Taisho Pharmaceutical Co., Ltd. | Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
JPWO2004089966A1 (ja) | 2003-04-01 | 2006-07-06 | 大正製薬株式会社 | 選択的なヘテロアリール5−チオ−β−D−アルドヘキソピラノシドの製造法 |
JP4708187B2 (ja) | 2003-06-20 | 2011-06-22 | キッセイ薬品工業株式会社 | ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体 |
ATE422204T1 (de) | 2003-08-26 | 2009-02-15 | Boehringer Ingelheim Int | Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
US7375090B2 (en) * | 2003-08-26 | 2008-05-20 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof |
AR054852A1 (es) | 2005-07-22 | 2007-07-18 | Boehringer Ingelheim Int | Procesos para preparar derivados de pirazol 0- glucosido y nuevos intermediarios de dichos procesos |
UY29694A1 (es) | 2005-07-28 | 2007-02-28 | Boehringer Ingelheim Int | Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
US20080020987A1 (en) | 2006-07-20 | 2008-01-24 | Waldemar Pfrengle | Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes |
-
2007
- 2007-01-05 UY UY30082A patent/UY30082A1/es not_active Application Discontinuation
- 2007-01-09 PE PE2007000017A patent/PE20071237A1/es not_active Application Discontinuation
- 2007-01-10 BR BRPI0706375-0A patent/BRPI0706375A2/pt not_active IP Right Cessation
- 2007-01-10 AU AU2007204368A patent/AU2007204368A1/en not_active Abandoned
- 2007-01-10 TW TW096100941A patent/TW200745149A/zh unknown
- 2007-01-10 JP JP2008549026A patent/JP4936234B2/ja not_active Expired - Fee Related
- 2007-01-10 CN CNA2007800030344A patent/CN101370816A/zh active Pending
- 2007-01-10 WO PCT/EP2007/050209 patent/WO2007080170A1/en active Application Filing
- 2007-01-10 EP EP07703756A patent/EP1976859A1/en not_active Withdrawn
- 2007-01-10 EA EA200801663A patent/EA200801663A1/ru unknown
- 2007-01-10 CA CA002635203A patent/CA2635203A1/en not_active Abandoned
- 2007-01-10 NZ NZ570311A patent/NZ570311A/en unknown
- 2007-01-10 AR ARP070100090A patent/AR058962A1/es unknown
- 2007-01-10 US US11/621,859 patent/US7524822B2/en not_active Expired - Fee Related
- 2007-01-10 KR KR1020087019563A patent/KR20090012205A/ko not_active Application Discontinuation
-
2008
- 2008-05-14 ZA ZA200804151A patent/ZA200804151B/xx unknown
- 2008-05-27 NO NO20082395A patent/NO20082395L/no not_active Application Discontinuation
- 2008-06-04 EC EC2008008501A patent/ECSP088501A/es unknown
- 2008-07-07 IL IL192655A patent/IL192655A0/en unknown
-
2009
- 2009-03-16 US US12/404,442 patent/US7838500B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4936234B2 (ja) | 2012-05-23 |
AR058962A1 (es) | 2008-03-05 |
NO20082395L (no) | 2008-07-31 |
PE20071237A1 (es) | 2008-01-15 |
EP1976859A1 (en) | 2008-10-08 |
ZA200804151B (en) | 2009-10-28 |
CN101370816A (zh) | 2009-02-18 |
US20070244176A1 (en) | 2007-10-18 |
IL192655A0 (en) | 2009-02-11 |
US20090181905A1 (en) | 2009-07-16 |
US7524822B2 (en) | 2009-04-28 |
WO2007080170A1 (en) | 2007-07-19 |
CA2635203A1 (en) | 2007-07-19 |
TW200745149A (en) | 2007-12-16 |
EA200801663A1 (ru) | 2009-02-27 |
ECSP088501A (es) | 2008-07-30 |
NZ570311A (en) | 2010-05-28 |
BRPI0706375A2 (pt) | 2011-03-22 |
JP2009522340A (ja) | 2009-06-11 |
US7838500B2 (en) | 2010-11-23 |
KR20090012205A (ko) | 2009-02-02 |
AU2007204368A1 (en) | 2007-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30082A1 (es) | Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos | |
BRPI0818893B8 (pt) | compostos de tropano, suas composições farmacêuticas, seus usos e método in vitro de inibição de hsp90 em uma célula | |
PA8791801A1 (es) | Compuestos de pirazol | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
ECSP11011181A (es) | Compuestos orgánicos | |
DK1711481T4 (da) | Krystallinsk monohydrat som kinaseinhibitorer | |
MY153921A (en) | Aminopyrazole derivatives | |
CL2007003791A1 (es) | Compuestos derivados de piperidina, inhibidores de la proteina quinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para inhibir el crecimiento celular anormal. | |
SMAP200800048A (it) | Derivati pirimidinici utilizzati come inibitori dip13-chinasi | |
CL2012001348A1 (es) | Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry. | |
DOP2011000174A (es) | Compuestos organicos | |
ZA200904138B (en) | Substituted spirochromanone derivatives as acc inhibitors | |
DK1948643T3 (da) | 3-Alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-on-derivater som mellemprodukter i syntese af renininhibitorer | |
CY1106902T1 (el) | Κρυσταλλικη μορφη μηλεϊνικης ασεναπινης | |
SMAP200900065A (it) | Derivati ciclizzati come inibitori di eg-5 | |
PL2325181T3 (pl) | Inhibitor STAT3 zawierający jako składnik aktywny pochodną chinolinokarboksyamidu | |
AU2007306104A1 (en) | Hydrobenzamide derivatives as inhibitors of Hsp90 | |
GT200800251A (es) | Nitrilos espirociclicos como inhibidores de proteasa | |
UA99787C2 (en) | Lactams as beta secretase inhibitors | |
ES2530578T3 (es) | Cristales y cristales reticulados de Proteína A y métodos de uso de los mismos | |
DK2049480T3 (da) | 2-arylindolderivater som mPGES-1-hæmmere | |
CR10787A (es) | Substituted pyrazole and triazole compounds as ksp inhibitors | |
ECSP099442A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
SG148179A1 (en) | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | |
DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170526 |